We are a biotechnology company who apply our ion channel expertise to support our customers by supplying them with cutting edge automated patch clamp systems, ion channel cell lines and patch clamp reagents, or in-house patch clamp screening services.

We offer screening on our automated patch clamp platform, the CytoPatchâ„¢, as well as on manual patch clamp systems. Several important drugs have been withdrawn from the market due to their blocking effects on the hERG channel. Just one of the services we offer is the determination of hERG blocking by drug candidates on our GLP approved CytoPatchâ„¢ system.